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A B ST R AC T  
 
Aim: To evaluate the role of diffusion-weighted magnetic resonance imaging (DW-MRI) in 
differentiating enlarged cervical lymph nodes due to tularemia and metastatic tumors. 
Methods: We evaluated 59 patients with cervical lymphadenopathy (LAP) (32 patients with 
tularemia, 27 patients with metastatic tumors), retrospectively. We analyzed contrast enhancement 
patterns of LAP in postcontrast fat sat T1WI. We evaluated T2, DWI, and ADC signals of LAP in a 
5-point scale system. Moreover, the mean ADC values of solid and necrotic LAP in both groups were 
quantitatively measured and compared statistically. Receiver operating characteristic curves of 
quantitative ADC values were obtained to determine the diagnostic performance. 
Results: There was no difference between solid and necrotic LAP enhancement patterns in two 
groups. Solid LAP and peripheral parts of necrotic LAP showed diffusion restriction, whereas central 
parts necrotic LAP had high ADC and low DWI signal in both tularemia and metastatic groups. Signal 
characteristics were similar in two groups. In solid LAP, there was no significant difference between 
ADC values in two groups. In necrotic LAP, total, central, and peripheral quantitative ADC 
measurements were higher in the metastatic group than in the tularemia group. 
Conclusions: Conventional MRI findings were not sufficient to differentiate metastatic LAP from 
tularemia. DW-MRI was not helpful in solid LAP; however, ADC values of metastatic necrotic LAP 
were significantly higher than tularemia. Microagglutination tests would be useful for differentiation; 
however, DW-MRI might also be useful for differentiation and may expedite the diagnosis. 
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Introduction 
Tularaemia is a zoonotic bacterial infectious 
disease caused by a gram-negative 
coccobacillus, Francisella tularensis. It is a rare 
pathogen for the urban population; however, it 
is more common in rural areas and a potential 
agent for bioterrorism. Diagnosis of tularaemia 
is difficult due to; its rarity and inconsistency of 
clinical findings, fastidious nature that causes 
weak growth in standard culture media, and 
confusing histopathological appearance 
mimicking tuberculosis [1-4]. 
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The disease is commonly found in the soft 
tissue of the head and neck region. Imaging is 
mainly used to show the lesion and its 
extension. Since tularaemia is usually presented 
as neck masses with confusing clinical findings, 
differentiating them from malign 
lymphadenopathies is essential. Therefore, in 
addition to conventional contrast-enhanced 
MRI, diffusion-weighted magnetic resonance 
imaging (DW-MRI) findings could be helpful 
for differential diagnosis. DW-MRI is a 
recognized and reliable tool to evaluate and 
characterize lymph nodes. It is based on 
diffusion properties of water protons in biologic 
tissues, including the diffusion of molecules in 
extracellular or intracellular spaces as well as in 
cell membranes. There were numerous reports 
of DW-MRI characterization of malign, and 
benign lymph nodes might be completed 
without the need for invasive procedures [5-8].  
The aim of this study is to evaluate the DW-
MRI features of lymph node involvement due 
to tularemia and metastatic tumors in the head 
and neck region and to show the similarities and 
differences between them. 
 
Materials and Methods 
We obtained medical records of the patients 
who had tularaemia diagnosis serologically in 
our institution between June 2009 and June 
2019. All patients underwent neck 
ultrasonography (US) and neck magnetic 
resonance imaging (MRI). Ethics committee 
approval was obtained and informed consent 
was waived by ethics committee because of the 
retrospective study design. Informed consent 
was waived because of the retrospective design 
and institutional ethical board approved our 
study (Decision No: 2020/28 Date: 18.02.2020) 
Patients were divided into two main groups as 
tularemia and metastasis. Both groups were 
divided into two subgroups as solid and 
necrotic. Serological diagnosis of tularaemia 
was made with the existence of specific 
antibody titers of ≥1:160 or with at least a 
fourfold increase of antibody titer in two serum 
samples taken two weeks apart in patients with 
clinical findings and symptoms which is 
compatible for tularaemia [9]. Thirty-nine 
patients were meeting these criteria. We 
excluded seven patients because they had 
undergone biopsy or surgical drainage before 
the MRI examination.  
Patients in the metastatic group, who had a 
histopathological diagnosis of metastasis and 
neck US and neck MRI in our hospital between 
June 2009 and June 2019, were obtained. 
Twenty-nine patients were meeting these 
criteria. We excluded two patients from the 
study. One of the patients had insufficient 
biopsy material and discontinuation of the 
follow-up. Other patient presented with 
caseified granulomatous lymphadenitis. 
All patients underwent MRI examination with 
a 1.5 Tesla MRI machine (Symphony; Siemens 
Medical Systems, Erlangen, Germany). A head 
and neck surface coil was used. MR images of 
patients were uploaded to a workstation 
(syngoMMWP VE25A, Siemens AG, Berlin, 
and Munich, Germany) for evaluations and 
measurements. Neck US images were not in 
PACS; therefore, we used US reports for 
comparisons. 
MRI technique 
T1-weighted images (TR/TE of 800/20 ms) and 
T2-weighted fast spin-echo images (TR/TE of 
6.100/85 ms) were obtained from all patients. 
For MR images, the section thickness was 5 
mm, interslice gap was 1–2 mm, field of view 
(FOV) was 25–30 cm, and the acquisition 
matrix was 256x224. For diffusion-weighted 
magnetic resonance imaging (DW-MRI), a 
multislice, single-shot, spin-echo, echo-planar 
imaging sequence was used. The section  
                                              Hizal et al / Exp Biomed Res. 2020; 3(4):239-247 

























































































Figure 1. Metastatic necrotic LAP on the right side 
of the neck. (A) Central hyperintensity on Axial T2 
weighted image. (B) LAP shows peripheral 
enhancement on T1 weighted image after contrast 
administration. (C) Axial DW-MRI of the necrotic 
LAP shows slight hypointensity on the central part 
and hyperintensity of the peripheral part of the lesion. 
(D) On the axial ADC image, necrotic LAP shows 
hyperintensity on the central part. 
 
Figure 2. Metastatic solid LAP on the left side of 
the neck. (A) LAP shows intermediate signal on 
Axial T2 weighted image, (B) homogenous 
enhancement on T1 weighted image after contrast 
administration, and (C and D) restricted diffusion 
on DW-MRI. 
 
Figure 3. Necrotic LAP in tularemia on the left side 
of the neck. (A) Central hyperintensity on Axial T2 
weighted image, (B) peripheral enhancement on 
postcontrast T1 weighted image. (C) Axial DWI of 
the necrotic LAP shows slight hypointensity on the 
central part of the lesion in comparison to 
hyperintensity of the peripheral part and (D) 
hyperintensity on the central part on axial ADC 
image. 
Figure 4. Solid LAP in tularemia on the right side 
of the neck. (A) LAP shows a slightly high signal 
on Axial T2 weighted image, (B) homogenous 
enhancement on T1 weighted image after contrast 
administration, and (C and D) restricted diffusion 
on DW-MRI. 
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thickness was 5 mm, TR:0.300 ms, TE: 70 ms, 
FOV read 400 mm, and FOV phase 66.7%. 
DW-MRI was obtained with a diffusion factor 
b of 0, 400, and 800 s/mm2 with ADC maps in 
all patients. 
Image interpretation 
Images and information of a total of 59 patients, 
32 in the tularaemia group and 27 in the 
metastasis group, were scanned from the 
hospital information system. MRI and DW-
MRI were evaluated by two radiologists who 
had one year and ten years of experience in 
radiology with a consensus reading. Image 
interpretation was blinded to clinical 
information. 
We used the largest lymphadenopathies (LAP) 
in the evaluation. Lymph nodes that are larger 
than 1 cm in the smallest diameter and without 
cystic or necrotic component on US reports, 
with high DW-MRI and low ADC signal on 
MRI, were defined as solid LAP. Necrotic LAP 
were considered the lesions which were defined 
as cavitary lesions on US reports and had low 
DW-MRI and high ADC signal on MRI (Figure 
1-4). In homogenously enlarged lymph nodes 
(solid LAP), a region of interest (ROI) was 
placed inside the margins of the lesion to 
measure ADC value. When there was 
heterogeneity in signal intensity of the lesion, a 
larger ROI for whole lesion and two smaller 
ROIs were placed within both cystic-necrotic 
areas and areas which showed enhancement 
after gadolinium administration. Mean ADC 
values of regions with high and low ADC 
signals were calculated separately. 
We made minimal ROI size determination 
based on parameters suggested before [10]. 
Minimal ROI size was equal or larger than the 
voxel size to prevent partial volume effect 
would not produce unreliable measurements. 
We calculated the voxel size of each DWI-
sequence separately using FOV, matrix size, 
and slice thickness parameters. ROI size, which 
is smaller than this calculated voxel size, was 
not applied. 
The signal intensities of the lesions on T2, DW-
MRI and ADC map images were visually 
compared to the adjacent muscle using a 5-
point scale system: 1: hypointense, 2: 
moderately hypointense, 3: isointense, 4: 
moderately hyperintense, 5: significantly 
hyperintense. Because the DW-MRI sequence 
had a low spatial resolution, borders of ROI 
were defined with the guidance of conventional 
MRI. We made the quantitative ADC 
measurements on ADC map images. Mean 
ADC values, which were measured by the same 
two radiologists, and the differences were 
decided with a consensus. 
Statistical analysis 
Quantitative variables are summarized with 
mean ± standard deviation values. Qualitative 
variables were compared with the Chi2 test 
between the two groups. Because of continuous 
variables did not provide the assumption of 
normality, non-parametric Mann Whitney U 
test was used to compare the groups. We 
performed data analysis in SPSS 25.0 program 
(SPSS Inc., Chicago, Illinois, USA) and 




In the tularaemia group (n: 32), there were 
18(56%) solid, 14(44%) necrotic LAP. In the 
metastatic group (n: 27), there were 18(67%) 
solid and 9(33%) necrotic LAP.  In the 
tularaemia group, 20(62%) of the patients were 
male, 12(38%) of the patients were female. In 
the metastatic group, 20(74%) of the patients 
were male, 7(26%) of the patients were female 
(Table 1). The mean age and age range of the 
patients in the tularaemia and metastatic groups 
were shown in table 2.  
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All necrotic LAP, regardless of tularaemia or 
metastatic group, showed peripheral contrast 
enhancement. In patients with solid LAP, we 
found homogeneous contrast involvement in 13 
patients in the tularaemia group, 11 patients in 
the metastasis group, 5 patients in the 
tularaemia group, and 7 patients in the 
metastasis group. There was no significant 
difference between solid and necrotic LAP 
enhancement patterns in tularaemia and 
metastasis groups (p>0.05).   
T2 signal was high in all lesions, mostly in the 
central part of necrotic LAP. Solid LAP and 
peripheral parts of necrotic LAP showed high 
DWI and low ADC signal, whereas DWI and 
ADC signals of central parts of necrotic LAP 









There was no significant difference between 
tularaemia and metastasis groups in terms of 











In solid LAP patients, there was no significant 
difference between ADC measurements in 
tularemia and metastasis groups. In necrotic 
LAP patients, total, central and peripheral ADC 
measurements were significantly higher in the 
metastatic group than in the tularemia group. 
According to the ROC analysis, ADC cut-off 
values were found to be 1.915×10−3 mm2/s 
(Sensitivity: 81.8%, Specificity: 78.6%, AUC: 
0.799, p=0.012) for central portions of necrotic 
LAP, 0.815×10−3 mm2/s (Sensitivity: 81.8%, 
Specificity:50%, AUC: 0.773, p=0.021) for 
peripheral portions of necrotic LAP and 
1.345×10−3 mm2/s (Sensitivity:90.9%, 
Specificity:78.6%, AUC: 0.851, p=0.003)  for  
total part of necrotic LAP to differentiate 
metastatic and tularemia groups in necrotic 
LAP (Figure 5). 
 
Discussion 
We found that necrotic LAP had significantly 
higher ADC values in the metastatic group in 
comparison to tularaemia. Differentiation of 
malign LAP from tularaemia cases with head 
and neck involvement in MRI or DWI might 
not be possible and could cause a diagnostic 
dilemma. In this case, if the LAP is necrotic, 
ADC values have diagnostic value for 
differentiation of metastasis.  
Table 1. Demographic information (sex). 
 
Parameters Metastatic Tularemia Total 
Male 20 20 40 
Female 7 12 19 
Total 27 32 59 
 
Table 2. Demographic information (age). 
 
  













age 54,3 59 52,5  51,7  53,9  
Age 
range 24-76 25-78  22-71  20-68 20-78  
 
Table 3. Qualitative mean MRI scores of tularemia 
and metastatic solid lymphadenopathies. 
 
Sequence Tularemia Metastasis p 
T2WI 4.1 4 0.923 
DW-MRI 4.8 4.66 0.865 
ADC 1 1.22 0.629 
 
Table 4. Qualitative mean MRI scores of tularemia 
and metastatic necrotic lymphadenopathies. 
 
Central  Peripheral  
T2WI DWI ADC T2WI DWI ADC 
Tularaemia 5.0 2.71 5.0 3.93 4.54 2.3 
Metastasis 5.0 2.27 5.0 3.72 4.81 2.18 
p 1.0 0.226 1.0 0.563 0.061 0.857 
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In our study, both tularaemia and malignant 
solid LAP had low mean ADC values and were 
hypointense on ADC and had similar mean 
ADC values. In previous studies, the mean 
ADC values in metastatic LAP were reported as 
0.59 ± 0.27 × 10−3 mm2/s, 0.78 ± 0.09 × 10−3 
mm2/s, 0.85 + 0.27 × 10−3 mm2/s [12-14]. 
Furthermore, there are several reported cases of 
LAP with granulomatous reaction such as 
sarcoidosis and cat scratch disease, that present 
low ADC values resembling malignancy [10, 
15, 16]. The reason for restricted diffusion in 
tularaemia might be the ability of the pathogen 
to impair phagocyte function, and thus survive 
in the infected cells [17]. 
We found that ADC and T2 signals were high 


























groups. This situation was also similar for 
metastatic necrotic LAP and contrary to 
necrotic lymphadenitis in the study of Koç et al. 
[18]. However, in qualitative evaluation, mean 
ADC values of central parts and the total of 
necrotic LAP were significantly higher in the 
metastatic group than the tularaemia group. 
When thresholds of mean ADC values were 
determined as 1.915×10−3 mm2/s for the central 
part and 1.345×10−3 mm2/s for the total of 
necrotic LAP, differentiation is probable with 
high sensitivity and specificity. Since necrosis 
is a factor that increases diffusion, ADC values 
of the peripheral solid parts of the necrotic 
LAP, which are viable, were similar to the ADC 
values of LAP without necrosis. However, 
diffusion increases in the necrotic parts, 











Tularemia 0.74 ± 0.05 1.21±0.21 1.76±0.44 0.80 ±0.05 
Metastasis 0.76 ± 0.12 1.67±0.35 2.32±0.49 0.92± 0.20 
P 0.372 0.002* 0.011* 0.021* 
 
 
Figure 5. ROC analysis of ADC values according to total, central, and peripheral parts of necrotic LAP to 
discriminate tularaemia from metastasis. 
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regardless of emerging due to tularaemia or 
malignant causes [19]. In our study, central, 
peripheral, and total ADC values of necrotic 
LAP were significantly higher (p=0.011) in the 
metastatic group than in the tularaemia group 
by the quantitative ADC evaluation. Koç et al. 
reported that ADC values of tumoral necrotic 
lymph nodes were significantly higher than 
those of infective necrotic lymph nodes, and 
they attributed that the movement of water 
molecules was freer than infective necrosis with 
high protein content, as a reason of this. 
Whereas Koç et al. reported that infective 
necrotic lymph nodes were hyperintense in 
DWI, DWI was hypointense in the necrotic 
parts of LAP in tularaemia group in our study 
[18]. However, ADC values of tumoral necrotic 
LAP were significantly higher than necrotic 
LAP in tularaemia. This condition is thought to 
be related to the intense content with necrosis 
in tularaemia, and it can be used as a parameter 
to differentiate tularaemia-metastasis. 
However, considering that this situation may be 
due to the low number of our study population, 
studies with a larger population are needed on 
this subject. 
Although the mean ADC values of the 
peripheral part of the necrotic LAP were also 
significantly higher in metastatic groups than 
the peripheral group, specificity was lower than 
the central parts or total of the necrotic LAP. 
This condition might be due to the effect of 
large central necrotic part of the LAP on the 
thin peripheral part in which ROI placed 
because of the low resolution of DWI. 
There were certain limitations to this study. 
First, since a limited patient population might 
restrain the results, they should be confirmed on 
a larger scale. Second, US or fine-needle 
aspiration could not be performed by us, and we 
obtained the reports of these procedures from 
the archives. Third, we evaluate images with a 
consensus of two observers, so we did not 
assess interobserver variability. 
Both tularaemia and metastases cause solid and 
necrotic LAP in the neck. Conventional MRI 
findings do not provide sufficient information 
to differentiate these lesions. There was no 
significant difference in tularaemia and tumour 
in terms of signal characteristics in solid LAP. 
Since tularaemia is an infectious disease, 
clinical findings might be considered useful in 
differentiation; however, confusing clinical 
presentation is not uncommon in tularaemia. 
Microagglutination test will be useful in the 
evaluation of these lesions. The 
microagglutination test might be used in 
necrotic LAP; however, despite tularaemia and 
tumour signal characteristics are similar, higher 
ADC values might favour the diagnosis of 
tumour in necrotic LAP than tularaemia and 
might be useful for differentiation and may 
expedite the diagnosis. 
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